Clinical data required for the approval of pediatric pharmaceuticals in Japan
Abstract Background In Japan, the number of pharmaceuticals with pediatric indications is low, and some are approved only in Europe or the USA but not in Japan. As the approval review report by the Japanese health authority contains any detailed items considered for drug approval, this study aimed t...
Saved in:
| Main Authors: | Hisamitsu Haigo, Kenji Matsuda, Mayumi Shikano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12887-025-05646-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01) -
Problems and Solutions of Pharmaceutical Packaging in Bulk
by: R. Yu. Garankina, et al.
Published: (2025-07-01) -
Evaluation of rheumatologists’ knowledge of biosimilars
by: Thayane Furtado Rolim Lima, et al.
Published: (2025-07-01) -
CORRIGENDUM: Problems and Solutions of Pharmaceutical Packaging in Bulk [Pharmacy & Pharmacology. 2025;13(2):128-138. DOI: 10.19163/2307-9266-2025-13-2-128-138]
by: R. Yu. Garankina, et al.
Published: (2025-08-01) -
Regulatory efforts to address the access gap for foreign new drugs in China: the priority review program and related policies
by: Xingyue Zhu, et al.
Published: (2025-02-01)